Aegis Capital Corp. acted as Exclusive Placement Agent on a $3.5 Million Registered Direct and Private Placement for Polyrizon Ltd.
- Apr 13
- 2 min read
4/8/2026 - Aegis Capital Corp. acted as Exclusive Placement Agent on a $3.5 Million
Registered Direct and Private Placement for Polyrizon Ltd. (Nasdaq:PLRZ)
About Polyrizon Ltd.
Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Polyrizon’s proprietary Capture and Contain TM, or C&C, hydrogel technology, comprised of a mixture of naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a “biological mask” with a thin shield containment barrier in the nasal cavity. Polyrizon is further developing certain aspects of its C&C hydrogel technology such as the bioadhesion and prolonged retention at the nasal deposition site for intranasal delivery of drugs. Polyrizon refers to its additional technology, which is in an earlier stage of pre-clinical development, that is focused on nasal delivery of active pharmaceutical ingredients, or APIs, as Trap and Target ™, or T&T.
About Aegis Capital Corp.
Aegis Capital Corporation ("Aegis") has been in the wealth management and investment banking business since 1984. Aegis is dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Aegis also provides research and sales and trading services to institutional investors. Aegis offers its investment representatives a conflict free service platform and is able to provide a full-range of products and services including investment banking, wealth management, insurance, retirement planning, structured products, private equity, alternatives, equity research, fixed income and special purpose vehicles.
Private placement news feels far away from normal life until you think about how much people rely on service plans, warranties, and payment promises after the sale. A coworker once bought coverage for a device and only cared about one thing: would support actually explain what was included when something broke? By the time he needed help, https://www.pissedconsumer.com/company/extend/customer-service.html was the type of page that would make the process less blind. Investment headlines are big; customer support is where trust gets tested.
Great post, lots of good points realtimevoice here that really got me transitchart thinking. It's clear you put some real effort into this and it shows. This is good tools;
slope game is a challenge for those who want test the ability of handling in the platform with increasing speed.
This announcement highlights how biotech innovation like Polyrizon’s nasal hydrogel technology is continuing to attract funding support for medical device development and drug delivery research. After reading updates like this, I often take a short break with Slope Rider which is a fast-paced downhill game where you navigate obstacles and maintain speed for a quick mental reset.
What I like about Drive Mad is how it rewards patience. Rushing almost always leads to failure, so you really have to slow down and think about each move.